<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000225.v1.p1" parentStudy="phs000225.v1.p1" createDate="2009-11-04" modDate="2010-09-30">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Tomi Pastinen, MD, PhD</td><td>McGill University, Montr&#233;al, QC, Canada</td></tr>
		<tr><td>Co-Investigator</td><td>Elin Grundberg, PhD</td><td>McGill University, Montr&#233;al, QC, Canada</td></tr>
		<tr><td>Investigators (MrOs Sweden Study)</td><td>Magnus K. Karlsson, MD, PhD</td><td>Lund University, Lund, Sweden</td></tr>
		<tr><td>Investigators (MrOs Sweden Study)</td><td>&#214;sten Ljunggren, MD, PhD</td><td>Uppsala University, Uppsala, Sweden</td></tr>
		<tr><td>Investigators (MrOs Sweden Study)</td><td>Dan Mellstr&#246;m, MD, PhD</td><td>G&#246;teborg University, Gothenburg, Sweden</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Expression QTL (eQTL) Analysis in Human Primary Cells</StudyNameEntrez>
	<StudyNameReportPage>A Population Genomics Study Using a Disease-Targeted Cell model: Integration  	   of <i>cis</i>-eQTLs Discovered in Human Primary Osteoblasts with GWAS of Bone Phenotypes</StudyNameReportPage>
	<StudyTypes>
		<StudyType>eQTL</StudyType>
		<StudyType>Cohort</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>The common genetic variants associated with complex traits typically lie in non-coding DNA and may alter gene  	regulation in a cell type-specific manner. Consequently, the choice of tissue or cell model in the dissection of  	disease associations is important. We carried out an expression quantitative trait loci (eQTL) study of primary  	human osteoblasts (HOb) derived from 95 unrelated donors of Swedish origin, each represented by two independently  	derived primary lines to provide biological replication. We combined our data with publicly available information  	from a genome-wide association study (GWAS) of bone mineral density (BMD). The top 2000 BMD-associated SNPs were  	tested for cis-association of gene expression in HObs and in lymphoblastoid cell lines (LCLs) using publicly  	available data and showed that HObs have a significantly greater enrichment (threefold) of converging  	cis-eQTLs as compared to LCLs. The top 10 BMD loci with SNPs showing strong cis-effects on gene expression  	in HObs were selected for further validation using a staged design in two cohorts of Caucasian male subjects.  	All 10 variants were tested in the Swedish MrOS Cohort (n = 3014), providing evidence for two novel BMD loci  	(SRR and MSH3). These variants were then tested in the Rotterdam Study (n = 2090), yielding converging evidence  	for BMD association at the 17p13.3 SRR locus. The cis-regulatory effect was further fine-mapped to the proximal  	promoter of the SRR gene (rs3744270). Our results suggest that primary cells relevant to disease phenotypes  	complement traditional approaches for prioritization and validation of GWAS hits for follow-up studies.</p>  	<p>Reprinted from Grundberg E, Kwan T, Ge B et al., Genome Res Nov 2009, with permission from Genome Research,  	Cold Spring Harbor Press, PMID:<a href="http://www.ncbi.nlm.nih.gov/pubmed/19654370" target="_blank">19654370</a>.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p><b>Exclusion criteria</b></p>  	<p><i>cis-eQTL Study:</i>  		<ul>  			<li>Missing expression profiling</li>  			<li>Genotyping call rate &lt;70%</li>  		</ul>  	</p>  	<p><i>MrOS Sweden Study:</i>  		<ul>  			<li>Walk with aid</li>  			<li>Bilateral hip prosthesis</li>  			<li>Missing BMD or weight measurements</li>  		</ul>  	</p>  	<p><i>Rotterdam Study:</i>  		<ul>  			<li>Gender mismatch with typed X-linked markers</li>  			<li>Excess autosomal heterozygosity &gt; 0.336~FDR&gt;0.1%</li>  			<li>Duplicates and/or 1st or 2nd degree relatives using IBS probabilities &gt;97% from PLINK</li>  			<li>Ethnic outliers using IBS distances &gt; 3SD from PLINK</li>  			<li>Missing BMD or weight measurements</li>  		</ul>  	</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="18334548"/>
		</Publication>
		<Publication>
			<Pubmed pmid="19838192"/>
		</Publication>
		<Publication>
			<Pubmed pmid="19801982"/>
		</Publication>
		<Publication>
			<Pubmed pmid="18455228"/>
		</Publication>
		<Publication>
			<Pubmed pmid="19079262"/>
		</Publication>
		<Publication>
			<Pubmed pmid="18445777"/>
		</Publication>
		<Publication>
			<Pubmed pmid="19680542"/>
		</Publication>
		<Publication>
			<Pubmed pmid="17371163"/>
		</Publication>
		<Publication>
			<Pubmed pmid="17955331"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Bone Density"/>
		<Disease vocab_source="MESH" vocab_term="Osteoporosis"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Tomi Pastinen, MD, PhD</AttName>
			<Institution>McGill University, Montr&#233;al, QC, Canada</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Elin Grundberg, PhD</AttName>
			<Institution>McGill University, Montr&#233;al, QC, Canada</Institution>
		</Header>
		<Header title="Investigators (MrOs Sweden Study)">
			<AttName>Magnus K. Karlsson, MD, PhD</AttName>
			<Institution>Lund University, Lund, Sweden</Institution>
		</Header>
		<Header title="Investigators (MrOs Sweden Study)">
			<AttName>&#214;sten Ljunggren, MD, PhD</AttName>
			<Institution>Uppsala University, Uppsala, Sweden</Institution>
		</Header>
		<Header title="Investigators (MrOs Sweden Study)">
			<AttName>Dan Mellstr&#246;m, MD, PhD</AttName>
			<Institution>G&#246;teborg University, Gothenburg, Sweden</Institution>
		</Header>
		<Header title="Investigators (Rotterdam Study)">
			<AttName>Andr&#233; Uitterlinden, PhD</AttName>
			<Institution>Erasmus MC, Rotterdam, The Netherlands</Institution>
		</Header>
		<Header title="Investigators (Rotterdam Study)">
			<AttName>Fernando Rivadeneira, MD, PhD</AttName>
			<Institution>Erasmus MC, Rotterdam, The Netherlands</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>MOP-89935</AttName>
			<Institution>Canadian Institutes of Health Research, Ottawa, ON, Canada</Institution>
		</Header>
		<Header title="Funding Source (Rotterdam Study)">
			<AttName>175.010.2005.011, 911-03-012</AttName>
			<Institution>The Netherlands Organization of Scientific Research NWO Investments, The Netherlands</Institution>
		</Header>
		<Header title="Funding Source (Rotterdam Study)">
			<AttName>014-93-015; RIDE2</AttName>
			<Institution>Research Institute for Diseases in the Elderly, The Netherlands</Institution>
		</Header>
		<Header title="Funding Source (Rotterdam Study)">
			<AttName>050-060-810</AttName>
			<Institution>Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research, The Netherlands</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>no</DisplayPublicSummary>
	<StudyURLs>
		<Url name="Ensembl GRiD" url="http://www.regulatorygenomics.org"/>
	</StudyURLs>
	<StudyHistory><![CDATA[
<p><b>Osteoblast eQTL Study History</b>  		<ul>  			<li>December 2006 - December 2007: Sample collection and cell culture</li>  			<li>August 2007: Gene expression profiling of a subset of the samples (pilot study)</li>  			<li>September 2007 - August 2008: Gene expression profiling and whole-genome genotyping of the complete  			study cohort</li>  		</ul>  	</p>]]>
	</StudyHistory>
	<ConsentGroups>
		<ConsentGroup groupNum="100" shortName="Analysis" longName="Analysis only"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>JARDE</DacName>
      <DacFullName>Joint NIAMS-NIDCR Data Access Committee</DacFullName>
      <DacEmail>jardedac@mail.nih.gov</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl>http://grants.nih.gov/grants/gwas</DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000225.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
               http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000225.v1.p1
            </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000225.v1.p1" FileName="eQTL_Pastinen_DUC.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>General Research Use</ConsentName>
        <ConsentAbbrev>GRU</ConsentAbbrev>
        <UseLimitation>This dataset may be used for any type of biomedical research.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
